CoChat

Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal: a case series

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Our group and others internationally have previously reported data on the use of low-dose flumazenil administered intravenously for the management of benzodiazepine withdrawal. This paper describes the first reported use of subcutaneous flumazenil infusion in the management of acute benzodiazepine withdrawal. Self-reported withdrawal symptoms and psychological state and anxiety sequelae were collected at baseline and then at intervals to 5 days following initiation of subcutaneous flumazenil infusion. Data indicate that patient subjective benzodiazepine withdrawal symptoms were well managed, with significant reduction in psychological distress seen over the duration of treatment. Perceived difficulty in performing everyday functions was positively correlated with withdrawal severity and improved over treatment. Patients reported high treatment comfort, willingness to undertake a future subsequent treatment using this technique, and willingness to recommend this treatment to a friend. This small proof-of-concept study indicates that subcutaneous flumazenil infusion has excellent tolerability, efficacy and improvement on measures of psychological distress. Given this technique is less invasive and requires fewer staff resources compared with intravenous administration, it may prove a significant asset in the management of benzodiazepine withdrawal.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881112446532

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 22 references

Research works printed but not linked: 1

  1. SA Health, 2009, Benzodiazepine equivalents for oral drugs available in Australia

Cited by

See all 27

Metadata

Authors
Hulse, G., O’Neil, G., Morris, N., Bennett, K., Norman, A., & Hood, S.
Affiliations
  • The University of Western Australia (AU)
  • Australian Medical Procedures Research Foundation (AMPRF), Perth, Australia
Venue
Journal of Psychopharmacology
Published
2012-05-16
Volume
27
Issue
2
Pages
222-227
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W1971774209
Cited by
27
References
22
Citations by year
2026: 1 · 2023: 2 · 2022: 6 · 2021: 4 · 2020: 1 · 2017: 2 · 2016: 4 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 1
FWCI
1.68
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
Keywords
benzodiazepine withdrawal, flumazenil, withdrawal symptoms, psychological distress, anxiety, patient satisfaction, treatment tolerability, benzodiazepine dependence
MeSH terms
Adult, Aged, Anxiety Disorders, Benzodiazepines, Female, Flumazenil, Humans, Male, Middle Aged, Substance Withdrawal Syndrome, Patient Satisfaction, Infusions, Subcutaneous

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal: a case series. https://app.cochat.ai/papers/10.1177/0269881112446532
The paper
Hulse, G., O’Neil, G., Morris, N., Bennett, K., Norman, A., & Hood, S. (2013). Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal: a case series. Journal of Psychopharmacology. https://doi.org/10.1177/0269881112446532

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.